Brain

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that…

1 week ago

BoomRx Debuts Single Portal for Prescription Sourcing and Fulfillment

New Technology Platform Reduces Administrative Burden for Healthcare Providers NationwideTAMPA, Fla., Dec. 12, 2025 /PRNewswire/ -- BoomRx, a fast-growing national…

1 week ago

BrainCheck Awarded $500K NIH SBIR Phase I Grant to Advance eConsult Platform for Cognitive Care

AUSTIN, Texas--(BUSINESS WIRE)--#CognitiveHealth--BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR…

1 week ago

Datasea Announces Breakthrough in Acoustic-Driven Brain-Computer Interface Technology

Developing Healthcare and Intelligent Interaction Through Core Acoustic InnovationBEIJING, Dec. 11, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or…

1 week ago

ZEISS celebrates 100 years of advancing innovation in the U.S.

Today, ZEISS marks 100 years of operation in the U.S., helping Americans improve lives and reach profound achievements by applying…

1 week ago

Vesalio Receives FDA 510(k) Clearance of enVast, the First Stent-Based Coronary Thrombectomy Technology

The FDA clearance of enVast redefines coronary thrombectomy treatment and further expands Vesalio's commercial platform.PLANO, Texas, Dec. 11, 2025 /PRNewswire/…

1 week ago

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology

Collaboration aims to automate RNA and protein detection in 3D tissue specimens, reducing complexity and technical barriers.Innovation has the potential…

1 week ago

BetterLife Pharma Announces Engagement with Shanghai-Based YAFO Capital

Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an…

1 week ago

Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026

EMBOLD data to serve as basis of efficacy and safety following discussion with the FDABOSTON, Dec. 11, 2025 (GLOBE NEWSWIRE)…

1 week ago

PatchMD Launches New Dopamine Support Patch for Natural Mood and Focus Support

Original Vitamin Patch Pioneer Introduces Comprehensive Dopamine Precursor Formula Backed by Clinical ResearchLas Vegas, NV, Dec. 11, 2025 (GLOBE NEWSWIRE)…

1 week ago